ADVANCES IN THE DIAGNOSIS AND TREATMENT OF LIVER CIRRHOSIS: EMERGING TECHNOLOGIES AND BIOMARKER-BASED APPROACHES

Abstract

Liver cirrhosis continues to represent a major clinical challenge in contemporary hepatology due to its progressive nature and association with a wide spectrum of systemic complications, particularly renal dysfunction. This article examines the importance of incorporating advanced medical technologies alongside innovative diagnostic and therapeutic approaches in the integrated management of patients with liver cirrhosis. The application of targeted pharmacological interventions, principles of regenerative medicine, and emerging biomarkers has significantly enhanced early disease detection, prognostic assessment, and therapeutic effectiveness in cirrhotic populations. Special emphasis is placed on the contribution of modern diagnostic modalities and individualized treatment strategies to improving clinical outcomes, enhancing quality of life, and extending survival in patients with liver cirrhosis. The adoption of state-of-the-art technologies offers substantial potential for advancing patient-centered care within hepatology practice.